Trial intelligence / Profile preview

Synergic Effects of Oxytocin and Psychotherapy in Postpartum Depression

2008-001913-51Phase 3Active

Sponsor
IRCCS Burlo Garofolo
Start
May 2008
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 3, randomised trial in postpartum depression (PPD) and postpartum blues comparing Oxytocin + introspective psychotherapy with Placebo + prescriptive psychotherapy (2 arms). Primary endpoint: Primary efficacy: improvement in postpartum depression parameters. Started May 2008; status: active.

02

Drugs

oxytocin
03

Conditions

postpartum depression (PPD)postpartum blues

Beyond the preview

Go deeper on 2008-001913-51.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001913-51.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call